Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle Diabetes Study.

@article{Davis2005DeterminantsOD,
  title={Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle Diabetes Study.},
  author={Wendy A Davis and Matthew William Knuiman and Delia V Hendrie and Timothy M E Davis},
  journal={Diabetes care},
  year={2005},
  volume={28 2},
  pages={
          329-36
        }
}
OBJECTIVE To prospectively examine the magnitude and predictors of diabetes-attributable non-blood glucose-lowering (non-BGL) medication costs in type 2 diabetes. RESEARCH DESIGN AND METHODS Detailed data from 593 community-dwelling patients were available over 4.3 +/- 0.4 years. Diabetes-attributable costs (in year 2000 Australian dollars [A$]) were calculated by applying a range of attributable proportions for each complication for which medication was prescribed. RESULTS Non-BGL… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 13 REFERENCES

DiabCost Australia: Assessing the Burden of Type 2 Diabetes in Australia

S Colagiuri, R Colagiuri, B Conway, D Grainger, P Davey
  • 2003
VIEW 2 EXCERPTS

Eco - nomic costs of diabetes in the U . S . in 2002

B Jönsson
  • Diabetes Care
  • 2003

Glyce - mic control in elderly subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study

DG Bruce, WA Davis, Davis TME
  • Diabet Med
  • 2000